Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial

Tarrex Biopharma, a San Diego-Xiamen biopharma, reported that the US FDA approved its Investigational New Drug (IND) application for TX803, a novel treatment for colorectal cancer. Tarrex licensed global rights to TX803 and related IP from the Sanford Burnham Prebys Medical Discovery Institute in San Diego. Privately owned Tarrex has an office in San Diego and a research facility in Xiamen. Xiaokun Zhang, PhD, Cofounder and Chief Scientific Advisor to Tarrex, is Dean of the School of Pharmaceutical Sciences at Xiamen University and Professor at Sanford-Burnham. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.